Growth Equity Explained: How the Strategy Works in 2026

Growth equity is a private investment strategy that buys a minority stake in a company that already has a working business model and meaningful revenue, and uses the new capital to accelerate expansion rather than to fund a search for product-market fit. Deals typically use little or no debt, founders usually stay in control, and the investor's return depends mainly on revenue growth rather than on financial engineering.

Definition: Growth equity is a minority, mostly unlevered equity investment in an established, fast-growing private company, made to fund expansion and typically held for 3 to 7 years before an exit.

Think of it as the middle rung of private markets: later and safer than venture capital, earlier and faster-growing than a leveraged buyout. Venture bets on what a company could become. Growth equity pays for what it already is, and bets it gets bigger.

An illustrative worked example: a hypothetical software company doing $30M in annual revenue, growing 40 percent a year and near break-even, raises $60M from a growth investor at a $240M pre-money valuation. The investor owns 20 percent post-money, takes a board seat, and the company uses the money to open two new markets and build a sales team. If growth moderates to about 32 percent a year and the company reaches $120M of revenue five years later, then sells for 6x revenue ($720M), the investor's 20 percent is worth $144M before any further dilution, a 2.4x gross multiple on the $60M invested.

No moonshot required. That's the point.

What growth equity is and where it sits

Carta's private funds guide describes growth equity as capital for established, high-growth companies in exchange for a significant minority stake, with founders remaining in operational control and little to no debt in the structure. PitchBook's description of growth deals makes the same point from the other side: the targets have strong revenue and proven business models but are either too small for a buyout or not growing fast enough for a venture fund to care.

Cambridge Associates, whose benchmarks are a standard reference for institutional investors, characterizes "classic" growth equity companies as founder-owned, with no prior institutional capital, no or limited leverage, a proven business model, substantial organic revenue growth (its research says usually above 10 percent and often above 20 percent), and EBITDA positive or expected to be within 12 to 18 months.

How a growth equity deal is structured

Most growth equity investments are primary capital (new shares issued by the company), sometimes combined with a secondary component that buys shares from founders or early investors who want partial liquidity. The instrument is usually preferred stock with terms that look familiar to anyone who has read a venture term sheet: a 1x non-participating liquidation preference, pro rata rights, information rights, and a board seat.

Where growth terms differ from an early-stage round:

• Governance is heavier. Protective provisions over budgets, debt, M&A, and executive hiring, often with a right to appoint an independent director.
• Redemption rights show up more often. Growth investors sometimes negotiate the right to be bought out after 5 to 7 years if no exit has happened.
• Diligence is financial, not narrative. Revenue by cohort, gross margin, net revenue retention, and a pipeline audit; the financial due diligence guide covers the workflow.
• Valuation is anchored to metrics. Revenue multiples and public comparables matter more than the story-based pricing common at seed.

At seed, the story sets the price. At growth, the spreadsheet does.

Growth equity returns: fewer losers, fewer moonshots

In our view, a big reason institutions allocate to growth equity separately from venture is the shape of the outcomes. Cambridge Associates' research on the strategy, using data as of June 30, 2018, found that growth equity incurred a loss on 13.7 percent of invested capital, against 32.7 percent for venture capital and a 10 to 15 percent range for buyouts. On data as of December 31, 2017, the same research found that about two thirds of realized, high-growth companies in growth equity portfolios (those growing revenue faster than 20 percent a year) reached a gross MOIC of 2.0x or better at exit.

Low loss rates and a high share of 2x outcomes suggest a growth fund doesn't need a single 50x winner to work. A venture fund often does. For anyone building a personal portfolio, that changes both the number of positions you need and the kind of diligence worth doing, a trade-off we cover in our view on portfolio size.

According to Cambridge Associates' US PE/VC benchmark commentary for calendar year 2025, the growth equity component of the US private equity index returned 11.9 percent for the year, compared with 7.6 percent for buyouts and 21.1 percent for the US venture capital index, where Cambridge points to the heavily weighted information technology sector as the main driver.

"But venture beat growth by about nine points"

It did in 2025: 21.1 percent against 11.9. So why accept the middle rung?

But one year is one year, and Cambridge credits much of venture's result to a heavily weighted technology sector. Growth equity's case was never that it wins every year. It's that the losses are smaller and the good outcomes more common. Some investors want that shape; others want the fat tail. Both are defensible.

Who does growth equity

Three kinds of firms commonly run the strategy: dedicated growth firms, growth arms of large venture franchises that keep backing their best companies past Series C, and minority growth funds inside buyout firms that apply operating playbooks without leverage.

Nontraditional investors matter too. Crossover funds, sovereign wealth funds, corporates and family offices all write growth-stage checks, and they tend to go where the money is. The 2026 NVCA Yearbook records $320 billion deployed across 15,352 US venture deals in 2025, with the five largest companies raising nearly $60 billion between them. Capital at that scale lands in the late-stage and growth rounds where growth equity competes, so a growth investor is often bidding against buyers who are not growth funds at all.

How to evaluate a growth equity opportunity

Whether you are an angel co-investing in a late round, an LP looking at a growth fund, or an aspiring investor learning the craft, we'd start with the same questions:

1. Growth quality. Is revenue growth above 20 percent, and is it organic rather than acquired or discounted?
2. Unit economics. Gross margin, payback period on customer acquisition, and net revenue retention above 100 percent for subscription businesses.
3. Path to profitability. Cambridge Associates' definition expects the company to be EBITDA positive already or within 12 to 18 months. If the plan needs three more rounds, we'd treat it as a venture deal wearing a growth label.
4. Use of proceeds. Is the money funding a specific, measurable expansion (new geography, new product line, sales headcount), or covering burn?
5. Cap table and preference stack. How many layers of preferred sit ahead of common, and what happens to your return in a modest exit? The investor-side cap table guide walks through the calculation.
6. Exit routes. Strategic buyers, sponsor buyers, and IPO. We like to see at least two credible routes at entry.
7. Governance. Board composition, information rights, and who can block a sale.
8. Downside protection. Liquidation preference, redemption rights, and any structured terms that trade upside for safety.

Common growth equity mistakes

• Paying venture prices for growth risk. If the loss rate is 14 percent rather than 33 percent, the entry multiple arguably needs to reflect a lower expected upside on the winners. Overpaying at $30M of revenue tends to be harder to grow out of than overpaying at $1M.
• Confusing late-stage venture with growth equity. A pre-profit company raising its fifth round at a high burn rate is, in our view, still venture risk, whatever the round is called.
• Ignoring the preference stack. In a growth round you are often sitting behind several earlier series. Model the waterfall at 1x, 2x, and 4x exit values before committing.
• Skipping the holding period math. Bain & Company's Global Private Equity Report 2026 says buyout holding periods at exit now hover at around seven years, up from an average of five to six years from 2010 to 2021. Growth deals exit into the same slow market. Cash tied up for seven years needs a higher multiple than cash tied up for four to earn the same annual return.

Where we land

Growth equity is a real strategy, not a label. The test we'd apply is simple: proven model, real growth, a visible path to profit, and a price that respects all three. Miss one and it's probably venture risk at a growth price.

That's our lens; an investor with a sector edge may draw the line elsewhere.

Where to learn the craft

Growth-stage diligence is a teachable process that, in our view, most people only learn inside a fund. That is the seat 1752vc's Emerging Angels program hands accredited investors who are new to angel investing: eight live weeks in a working fund's investment process, including the deal reviews where a multiple has to be defended out loud. Investors who know how a later-stage buyer reads a company tend to price the seed and Series A rounds ahead of it better.

For the broader map of private-market strategies, see private equity vs. venture capital and the comparison in growth equity vs. venture capital.

The bottom line

Growth equity trades the chance of a legend for the likelihood of a decent result. Whether that's a good trade depends on what your portfolio needs.

Venture pays for potential.

Growth equity pays for proof.

Key takeaways

• Growth equity is a minority, mostly unlevered investment in a proven, fast-growing company, used to fund expansion rather than discovery.
• Cambridge Associates' research found a 13.7 percent capital loss ratio for growth equity (as of June 2018) versus 32.7 percent for venture, with about two thirds of high-growth companies returning 2.0x gross or better.
• Growth equity returned 11.9 percent in calendar 2025 per Cambridge Associates, between buyouts (7.6 percent) and venture (21.1 percent).
• Deal terms look like venture preferred stock with heavier governance, more frequent redemption rights, and metric-driven valuation.
• We would evaluate growth deals on growth quality, unit economics, path to profitability, preference stack, and exit routes, and model the waterfall before investing.

Frequently asked questions

What is growth equity?

Growth equity is a private investment strategy that provides expansion capital to established companies with proven business models and strong revenue growth, in exchange for a minority ownership stake. Deals use little or no debt, and founders typically stay in control. It sits between venture capital and leveraged buyouts in both risk and return.

How is a growth equity deal structured?

Most growth equity deals are primary preferred stock issued by the company, sometimes with a secondary component buying shares from founders or early investors. Terms resemble a venture round (1x non-participating liquidation preference, pro rata and information rights, a board seat) with heavier protective provisions and, more often than at seed, redemption rights after 5 to 7 years. For the full comparison, see growth equity vs. venture capital.

How much do growth equity investors typically own?

Typically a minority stake, usually well under 50 percent. Exact percentages depend on round size and valuation, but in our view roughly 10 to 30 percent is a reasonable rule of thumb for a lead growth investor, paired with a board seat and protective provisions. Treat it as a rough guide; terms vary by deal and market.

What returns does growth equity generate?

According to Cambridge Associates' benchmark commentary, US growth equity returned 11.9 percent in calendar year 2025, against 7.6 percent for buyouts and 21.1 percent for US venture capital. Cambridge's 2018 research also found growth equity's fund-level returns stronger than venture capital in all periods of 15 years or fewer and comparable to buyouts. Individual funds vary widely.

Is growth equity considered private equity?

Generally, yes. Growth equity is commonly treated as one of the three main private equity strategies alongside buyouts and venture capital, and Cambridge Associates reports it as a component of its US private equity index. The distinguishing features are minority ownership, minimal leverage, and a focus on revenue growth.

Sources

• Carta: Growth Equity, Understanding the Entire Lifecycle
• Cambridge Associates: Growth Equity, Turns Out It's All About the Growth
• Cambridge Associates: US PE/VC Benchmark Commentary, Calendar Year 2025
• PitchBook: Characteristics of Growth Deals
• NVCA: 2026 NVCA Yearbook
• Bain & Company: Private Equity Resurgence Gathers Steam, Global Private Equity Report 2026